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Abstract
Introduction: According to the WHO, almost a third of the world population are thought to be infected with Mycobacterium tu-
berculosis. Some studies of the prevalence of latent tuberculosis infection (LTBI) have already been performed in Poland, showing 
that almost a quarter of the Mazovia population could be infected. It also indicated a higher prevalence of LTBI among seniors. 
Those studies were based on indirect diagnostic methods.
Material and methods: We randomly collected hilar lymph nodes from decedents aged 40 years and older during post-mortem 
examination. We excluded patients with previous confirmed tuberculosis. In addition, an autopsy was performed in all patients. 
Finally, we used real-time PCR Xpert MTB/RIF (Cepheid, USA) for the specific capture of mycobacterial DNA.
Results: Twenty-two of 23 patients had a negative result of the real-time PCR examination and no signs of caseous necrosis in 
hilar lymph nodes. We found the only positive sample in a patient with histopathological signs of tuberculosis (the presence of 
caseous necrosis in the specimens obtained from lymph nodes and lung). Due to the change of cartridges from version G3 to G4, 
further reactions were inhibited and no more post-mortem samples were tested. 
Conclusions: Real-time PCR Xpert MTB/RIF was capable of detecting M. tuberculosis complex DNA in a patient with tuberculo-
sis recognised on autopsy. In the remaining patients, no M. tuberculosis complex DNA was found, in accordance with negative 
results of histological examination. Since the technology of cartridges has changed, it is no longer possible to use real-time PCR 
Xpert MTB/RIF (Cepheid USA) on post-mortem material. 
Key words: M. tuberculosis complex DNA, latent tuberculosis infection, real-time PCR, Xpert MTB/RIF
Pneumonol. Alergol. Pol. 2014; 82: 430–435
Wojciech Rzechorzek et al., Detecting Mycobacterium tuberculosis complex DNA
431www.pneumonologia.viamedica.pl
Streszczenie:
Wstęp: Zgodnie z danymi Światowej Organizacji Zdrowia, uważa się, że prawie 1/3 światowej populacji jest zakażona prątkiem 
gruźlicy. Wyniki badań prowadzonych przy użyciu pośrednich metod diagnostycznych nad rozpowszechnieniem utajonego zaka-
żenia prątkiem gruźlicy w Polsce wykazały, że nawet 1/4 populacji Mazowsza może być zakażona, z przewagą u osób starszych.
Materiał i metody: Podczas badania post-mortem pobierano w sposób losowy węzły chłonne wnękowe od zmarłych w wieku 
40 lat i powyżej. Na podstawie danych z historii chorób wykluczono pacjentów leczonych z powodu gruźlicy w przeszłości. 
U wszystkich chorych przeprowadzono badanie sekcyjne. Następnie wykonywano badanie real-time PCR, Xpert MTB/RIF, Cephe-
id, USA w celu wykrycia DNA Mycobacterium tuberculosis complex.
Wyniki: U 22 z 23 pacjentów wynik reakcji real-time PCR był negatywny, a w preparatach węzłów chłonnych nie stwierdzono 
ziarniny serowaciejącej. W jednym przypadku badanie real-time PCR było dodatnie. Dotyczyło to chorego, u którego stwierdzono 
obecność ziarniny serowaciejącej zarówno w preparatach z węzłów chłonnych, jak i pobranych z nacieku płucnego. Po zmianie 
kartridży z wersji G3 na G4 w real-time PCR, Xpert MTB/RIF kolejne reakcje były zahamowane i nie testowano większej liczby 
próbek.
Wnioski: Badanie metodą real-time PCR, Xpert MTB/RIF wykazało obecność M. tuberculosis complex DNA u chorego z pośmiert-
nie stwierdzoną gruźlicą płuc i ww. chłonnych. U pozostałych chorych nie wykryto obecności DNA M. tuberculosis complex 
w tkankach, co pozostawało w zgodzie z negatywnym wynikiem badania histologicznego. Po zmianie technologii badania real-time 
PCR, Xpert MTB/RIF zawodzi przy badaniu próbek z materiału uzyskanego pośmiertnie.
Słowa kluczowe: gruźlica utajona, real-time PCR, Xpert MTB/RIF
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Introduction
According to the WHO, almost a third of 
the world population could be infected with 
M. tuberculosis [1]. In countries endemic for TB, 
the greatest number of new cases of tuberculosis 
is the result of recent contact with an infectious 
case of tuberculosis, whereas in developed coun-
tries with low prevalence of pulmonary TB, new 
cases of TB appear to be due to the reactivation 
of LTBI [2].
Latent tuberculosis infection (LTBI) is 
a condition in which M. tuberculosis is suppressed 
by the immune response of the host. Although 
tubercle bacillus does not replicate, it remains in 
old lesions. There are two models describing the 
possible location of the bacilli during the latency. 
In the “focal” model, M. tuberculosis remains in 
old granulomatous lesions and draining regional 
lymph nodes, which correspond to the Gohn 
complex. According to the “diffuse” model, ba-
cilli are distributed all over the lungs and other 
tissues [3]. A patient with LTBI does not transmit 
the disease, in contrast to the active form of tu-
berculosis (TB), in which the host infects up to 
10–30 people per year [4].
The incidence of tuberculosis per 100,000 
population in Europe is 50 in Lithuania and Es-
tonia and 10–20 in the United Kingdom, France, 
and Germany. In Poland after World War II the 
incidence of tuberculosis was very high, reaching 
over 300 per 100,000 population, and remained 
high until the 1960s, when it started to decrease 
gradually partly as a result of previous introduc-
tion of successful anti-tuberculous treatment [4]. 
Afterwards, the permanently declining incidence 
rate of tuberculosis led to similar levels to those 
seen in developed countries, i.e. 19.6 per 100,000 
population in 2012 [5].
The incidence notification rates of TB differ 
depending on the age group. Among seniors aged 
45–64 and 65+ the incidence is much higher than 
in other age groups, reaching 32.1 and 34.8 per 
100,000 population, respectively [5]. 
Likewise, the prevalence of LTBI according 
to the results of Kuś et al., based on interferon 
gamma release assay (IGRA), was higher among 
older people [6]. In this study it was shown that 
almost a quarter of the Mazovian population 
could be infected [6].
Taking into consideration the high preva-
lence of tuberculosis in Poland in the past and 
the positive correlation between IGRA results 
and age, it can be presumed that the incidence 
of tuberculosis among seniors nowadays could 
be the result of reactivation of latent infection.
Factors connected with the immunological 
status of the patient can facilitate the change from 
dormant bacilli state to clinical manifestation 
of tuberculosis. These include, among others, 
immunodeficiency due to immunosuppressive 
drugs, including anti-TNF therapy, or diseases 
such as diabetes, cancer, or HIV infection [7, 8].
People with latent infection have neither 
symptoms nor radiographic evidence of active TB. 
In the absence of bacilli in sputum or any clinical 
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probe, LTBI cannot be detected with classical mi-
crobiological methods, neither bacterioscopy nor 
culture. Consequently, there is no gold-standard 
test to determine LTBI. Current tools to diagnose 
LTBI include physical examination and history 
of TB contact. Tuberculin skin test (TST) and 
IGRA are indirect methods to investigate LTBI, 
based on the fact that after contact with bacilli, 
the lymphocytes of the human host are sensitised 
to M. tuberculosis antigens, and the immunolog-
ical memory persists. According to the indirect 
character of the tests, many false positive and 
false negative results can occur [9]. However, 
these tests cannot inform us with certainty about 
the current presence of tubercle bacilli and do 
not distinguish the past from present infection, 
regardless of whether or not it is active. Con-
sequently, the exact prevalence of LTBI is not 
known [10, 11].
Taking into consideration all of the epide-
miological and pathophysiological data, we de-
cided to establish whether it is possible to detect 
M. tuberculosis complex DNA by direct method, 
real-time PCR, in decedents aged 40 years and 
older, who were free from clinically recognisable 
tuberculosis in the past.
Material and methods
In the first step of our study we randomly col-
lected hilar lymph nodes from decedents aged 40 
years and older during post-mortem examinations 
(Fig. 1). Autopsies were performed on patients 
from the Central Clinical Hospital in Warsaw. The 
material was collected by anatomopathologists, 
placed into a physiological salt solution, and 
frozen at –20ºC.
In the second step, we analysed medical 
case histories, chest X-ray examinations, and/or 
computer tomography (CT) scans of decedents 
whose lymph nodes were collected. We excluded 
the material from patients with proven TB in the 
past. We also excluded the material from dece-
dents with signs of cavitation suggesting active 
TB. Autopsy was performed in all of the patients. 
Finally, to permit the specific capture of my-
cobacterial DNA, we used real-time PCR, Xpert 
MTB/RIF, version G3 (Cepheid, USA) [12]. We 
performed tests as an off label use on tissue spec-
imens, previously validated by our laboratory. We 
did not use any methods to purify the material 
from tissue inhibitors. We used the same proce-
dure as in sputum examination, as described in 
the manufacturer’s guidelines [13].
Results
We examined 23 patients within the age 
range of 40–97 years (average 70), 8 (35%) of 
whom were men. In all of the medical data, we 
found no signs of active TB. Eight of 23 patients 
had CT scans of the chest. Focal consolidations 
either in upper lobes or in superior parts of lower 
lobes and lymphadenopathy were present in four 
patients, and isolated lymphadenopathy in one 
case. No signs of cavitation were present in CT 
scans. Other results of CT scans are presented 
in Table 1. 
In the examined group, 22 out of 23 patients 
had a negative result of the real-time PCR and 
histopathological signs of tuberculosis were 
not found. The histological results and clinical 
diagnosis of patients are summarised in Table 1. 
The only positive sample was found in 
a 64-year-old patient with signs of tuberculosis. 
The autopsy revealed a 4 × 4 × 3 cm white/yel-
low amorphous lesion consistent with the foci of 
caseous necrosis, localised in the upper lobe of 
the right lung. Hilar lymph nodes were enlarged 
(2 cm in diameter). Microscopic necrosis and 
granulomatous reaction with multinucleate giant 
cells were present. The patient was referred to the 
neurosurgical department because of coma and 
severe subarachnoid haemorrhage. In addition, he 
suffered from diabetes and HCV infection. Blood 
tests, taken before death, revealed CRP — less 
than 5 mg/L [< 10 mg/L] and WBC of 24.15 × 
1000/mm3 [4–10 × 1000/mm3]. After four days of 
hospitalisation, the patient underwent brain-stem 
death. There was not enough data in case history 
or in X-ray examination to establish if the patient 
was symptomatic.
Figure 1. Hilar lymph nodes
Author: Benedykt Szczepankiewicz, MD, PhD Chair and Department 
of Pathomorphology (7 Pawińskiego str., 02–106 Warsaw, Poland)
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Table 1. Individual patients’ results
Gender Age real-time PCR 
result
P-positive
N-negative
Clinical 
diagnosis of 
tuberculosis
A-absent
P-present
Thorax CT scan pathologies Autopsy findings
Male 85 N A Bilateral massive consolidations; Enlarged 
para-aortic lymph nodes (l.n.)
Oedema/lung congestion
Male 62 N A Bilateral interstitial changes, glass-like infil-
trates; Enlarged right hilar and mediastinal 
l.n.; Bilateral pleural effusions
Oedema/lung congestion
Male 85 N A Perihilar inflammatory consolidation, left 
lung; Enlarged left, inferior, paratracheal 
l.n.; Nodules, left lung, interlobar fissure 
(<8mm); Bilateral pleural effusions
Oedema/lung congestion
Male 60 N A Bilateral enlarged axillary, mediastinal and 
cavital l. n.; Nodules, right lung, upper lobe 
(4 mm), medial lobe (3 mm) and lower lobe 
(6 mm); Focal fibrosis- left lung; Pleural  
effusions, left lung
Enlarged mediastinal lymph nodes
Female 63 N A Enlarged bilateral axillary, mediastinal and 
right cavital l.n.; Bronchial consolidations, 
right lung, upper and lower lobes; Consolida-
tions, left lung medial and lower lobes
Inflammatory changes in both lungs
Male 75 N A Congestion/atelectasis
Male 64 P P 4 × 4 × 3-cm white/yellow amorpho-
us lesion consistent with the foci of ca-
seous necrosis localized in upper lobe 
of the right lung, enlarged hilar lymph 
nodes (2 cm in diameter). Microscopi-
cally necrosis and granulomatous reac-
tion with multinucleate giant cells
Male 83 N A Oedema/lung congestion
Female 58 N A Oedema/lung congestion
Female 97 N A Nodules, bilateral, partially calcified (small) Massive bilateral pleural effusion
Female 80 N A Oedema/lung congestion
Female 70 N A Nodules left lung 9 seg. (4 and 5 mm) Bilateral 
basal atelectasis; Bilateral pleural effusions
Inflammatory changes in both lungs
Female 61 N A No changes
Male 63 N A Purulent bronchitis, emphysema, 
focal siderophages, congestion, focal 
oedema,
Male 64 N A Oedema/lung congestion
Male 54 N A Oedema/congestion, small focal  
fibrosis in right lung
Male 76 N A Congestion/atelectasis
Male 40 N A Oedema/congestion, purulent  
bronchitis
Female 58 N A Lung congestion
Female 89 N A Enlarged mediastinal l.n.; Focal change,  
right lung, 10th segment (15*20 mm)
Bronchopneumonia
Female 79 N A Lung tumour enlarged right hilar lymph 
nodes
Male 77 N A Atelectasis
Male 57 N A Enlarged axillar, mediastinal and cavital l.n.; 
Bilateral glass-like infiltrates (possible CMV 
aetiology); Bilateral basal subpleural nodules
Small nodule in the lower lobe of the 
right lung, oedema/congestion, enlar-
ged hilar lymph nodes
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Discussion
In spite of the vast knowledge of M. tubercu-
losis and numerous new methods to detect bacilli, 
there are still unanswered questions in the field of 
examinations. It is impossible to do the following: 
estimate the number of people that are infected 
in a latent manner; fully eliminate bacteria after 
the primary infection; or predict the risk of pro-
gression to the disease in patients with persistent 
anti-mycobacterial immune responses [10].
The percentage of people exposed to tuber-
culosis, who develop infection varies from 30 to 
95%, according to different specialists [1, 14]. The 
majority (90%) of people exposed to tuberculosis 
develop localized infection, which in up to 90% 
of cases leads to LTBI [15]. Reactivation of the 
infection is possible in 5-10% of those cases, even 
many years after the primary infection [16, 17].
In post-primary M. tuberculosis infection, 
radiological changes include focal consolida-
tions in upper lobes and superior parts of lower 
lobes, rarely accompanied by lymphadenopathy. 
Cavitation is a sign of active disease, with high 
infectivity and higher risk of complications [18]. 
In the present study, thorax CT scans were 
obtained in eight patients. Although lung pa-
thology was present in all of them, taking into 
consideration the negative histopathological ex-
amination and the lack of previous diagnosis of 
tuberculosis, none of them had signs consistent 
with active TB.
Most LTBI studies are based on indirect meth-
ods of investigation, including TST and IGRA [3, 19]. 
The aim of our study was to detect M. tuberculosis 
complex DNA using real-time PCR, Xpert MTB/ 
/RIF (Cepheid, USA) in material from patients with 
low probability of active tuberculosis. Although 
the method is designed to detect M. tuberculosis 
complex in sputum and BAL, it is also used with 
success to test the material from solid tissues, 
including extra-pulmonary locations [12, 20]. 
In a systematic review and meta-analysis, Denkinger 
et al. noted Xpert MTB/RIF pooled sensitivity of 
83.1% (95% CI 71.4–90.7%) and pooled specificity 
of 93.6% (95% CI 87.9–96.8%) against culture in 
material from lymph node tissues or aspirates [21]. 
This study included results from our laboratory. 
In four samples from mediastinal lymph 
nodes examined with real-time PCR during rou-
tine diagnostic procedure, two were positive and 
none of the reactions were inhibited [13]. The 
same procedure was performed by our group in 
14 different samples, with two positive results 
[unpublished data]. Tortoli et al. reported that 
in reference to the culture and clinical diagnosis 
of TB, sensitivity and specificity of Xpert MTB/
RIF reaches 81.3% and 99.8%, respectively [22]. 
According to some authors, there have been suc-
cessful attempts to detect DNA of M. tuberculosis 
complex in paraffin-embedded blocks already per-
formed using PCR amplification methods [23, 24].
We used Xpert MTB/RIF, which is based on 
the Automated Nucleic Acid Amplification Test 
and is capable of detecting even small amounts 
of DNA of M. tuberculosis complex. Furthermore, 
rpoB detected with real-time PCR is a very con-
servative gene present among M. tuberculosis 
complex. Markers used in real-time PCR detect 
mutations in this gene specific for M. tuberculosis 
complex, including ones responsible for resis-
tance to rifampicin. Research on tuberculosis 
shows superiority (greater specificity and sensi-
tivity) of real-time PCR over other methods, such 
as acid-fast bacilli culture or nested PCR [11]. 
The advantage of the test is the integrated internal 
control to monitor the validity of the assay, to ex-
clude negative result due to potential polymerase 
inhibitors present in tissues [25]. In the presented 
study, all reactions were valid according to per-
formed internal controls.
A drawback of the study with post-mortem 
material is that IGRA or TST are impossible. 
Therefore, we had only incomplete medical 
documentation, CT scans, and histopathological 
examination to evaluate clinical data and deter-
mine potential infections in patients.
Taking into consideration the high sensitivity 
and specificity of real-time PCR, the epidemiology 
of TB and LTBI, along with the age of the patients 
in our group, the chance of obtaining positive 
results seemed high. In our study we collected 
hilar lymph nodes, relying on the “focal” model 
of tuberculosis. However, the “diffuse” model of 
tuberculosis is a valid alternative, so, to some 
extent, the distribution of M. tuberculosis bacilli 
could be the cause of negative results. Because 
of financial limitations, it was not possible to 
examine whole lungs and all of the mediastinal 
lymph nodes, possible locations of M. tuberculosis 
according to the diffuse model.
In the only positive Xpert MTB/RIF case, 
histopathological examination confirmed the 
presence of caseous necrosis in lungs and regional 
lymph nodes, which, combined with a positive 
result of Xpert MTB/RIF, allowed us to recognise 
active tuberculosis according to the guidelines of 
the Polish Society of Lung Diseases [26]. 
Although initially we wanted to perform 40 
reactions, the technology of cartridges in real-time 
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PCR Xpert MTB/RIF (Cepheid, USA) has changed. 
The version (G3) that we were using was replaced 
by a new version (G4). The technological details 
of the change between versions of the cartridges 
were reserved by the manufacturer. We performed 
three reactions, which were inhibited, so we de-
cided to interrupt our study. Therefore, no more 
samples were tested.
Conclusions
Real-time PCR, Xpert MTB/RIF was capable 
of detecting M. tuberculosis DNA in a patient with 
tuberculosis recognised on autopsy.
In the remaining patients, no M. tubercu-
losis complex DNA was found, which was con-
sistent with the negative results of histological 
examination.
Since the technology of cartridges has 
changed, it is no longer possible to use Xpert 
MTB/RIF on post-mortem material.
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